我的账户 7×24小时客服热线:400-829-7929 语言:
热门产品: 人参皂苷Rh2,人参皂苷Rg3,胡萝卜苷, 木犀草苷
产品分类
在线咨询
联系电话:
销售:
400-829-7929(7*24小时)
028-82633860
028-82633397 
028-
82633165
技术服务和产品定制:
028-82633987
在线服务:  
沈帅 
文静  点击这里给我发消息
贺丹丹  
点击这里给我发消息
      
文献信息

Exploring potential coformers for oxyresveratrol using principal component analysis

期刊名:International Journal of Pharmaceutics
文献编号:
文献地址: https://www.sciencedirect.com/science/article/abs/pii/S0378517320306141
发表日期:25 September 2020
Abstract

Oxyresveratrol (OXY) exhibits poor bioavailability due to its low solubility. Cocrystals are effective in improving solubility of OXY. In this study, principal component analysis (PCA) was employed for coformer selection using 5 variables (solubility parameter, logP, hydrogen bonding acceptor, hydrogen bonding donor and molecular volume). According to PCA analyses, nicotinamide (NCT) and proline (PRO) were grouped as the potential coformers. OXY-PRO and OXY-NCT cocrystals were obtained using a liquid assisted grinding method. The thermal and diffraction characteristics of both cocrystals were different from their starting materials. Based on FTIR and Raman spectroscopy, both interactions between the amide group of NCT and the phenolic hydroxyl groups of OXY, as well as π-π interactions between the aromatic rings of OXY and the pyridine ring of NCT were involved in the cocrystal formation. For OXY-PRO cocrystal, the carboxylate group of PRO interacted with the hydroxyl groups of OXY, OXY-NCT and OXY-PRO cocrystals enhanced the solubility and dissolution of OXY. Accordingly, PCA proved to be an effective technique in screening potential coformers for OXY and probably for other compounds. The improved solubility and dissolution of OXY in the form of cocrystal may provide a benefit for the use of OXY for pharmaceutical applications.

… Finally, the solubility and dissolution of cocrystals were also evaluated. 2. Materials and methods. 2.1. Materials. OXY dihydrate and RES (Purity > 98.0%) was purchased from Chengdu Biopurify Phytochemicals Ltd. (Sichuan, China) …